PLoS ONE (Jan 2012)

MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θ.

  • Kara A Scheibner,
  • Brianne Teaboldt,
  • Mary Claire Hauer,
  • Xiaochun Chen,
  • Srujana Cherukuri,
  • Yin Guo,
  • Shannon M Kelley,
  • Zhenqiu Liu,
  • Maria R Baer,
  • Shelly Heimfeld,
  • Curt I Civin

DOI
https://doi.org/10.1371/journal.pone.0050895
Journal volume & issue
Vol. 7, no. 12
p. e50895

Abstract

Read online

MicroRNAs (miRs) play major roles in normal hematopoietic differentiation and hematopoietic malignancies. In this work, we report that miR-27a, and its coordinately expressed cluster (miR-23a∼miR-27a∼miR-24-2), was down-regulated in acute leukemia cell lines and primary samples compared to hematopoietic stem-progenitor cells (HSPCs). Decreased miR-23a cluster expression in some acute leukemia cell lines was mediated by c-MYC. Replacement of miR-27a in acute leukemia cell lines inhibited cell growth due, at least in part, to increased cellular apoptosis. We identified a member of the anti-apoptotic 14-3-3 family of proteins, which support cell survival by interacting with and negatively regulating pro-apoptotic proteins such as Bax and Bad, as a target of miR-27a. Specifically, miR-27a regulated 14-3-3θ at both the mRNA and protein levels. These data indicate that miR-27a contributes a tumor suppressor-like activity in acute leukemia cells via regulation of apoptosis, and that miR-27a and 14-3-3θ may be potential therapeutic targets.